Table 2.
Baseline characteristics of patients with mCRC grouped by the levels of LDH, SLA, and ALB.
| Contents | Sex | Age (year) | Locations (cancer) | Pathological type | Other treatment before chemotherapy | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | <56 | ≥56 | Rectum | Colon | Poor | Well | Yes | No | ||
| LDH | LDH≥225 | 9 | 5 | 4 | 10 | 6 | 8 | 7 | 7 | 2 | 12 |
| LDH<225 | 27 | 16 | 21 | 22 | 21 | 22 | 9 | 34 | 12 | 31 | |
| X2/t | 0.010 | 1.035 | 0.151 | 4.420 | 0.450 | ||||||
| P Value | 0.920 | 0.309 | 0.697 | 0.036 ∗ | 0.502 | ||||||
|
| |||||||||||
| SLA | SLA≥4.0 | 6 | 3 | 5 | 4 | 4 | 5 | 4 | 5 | 1 | 8 |
| SLA<4.0 | 30 | 18 | 20 | 28 | 23 | 25 | 12 | 36 | 13 | 35 | |
| X2/t | 0.000 | 0.589 | 0.000 | 0.620 | 0.360 | ||||||
| P Value | 1.000 | 0.433 | 1.000 | 0.431 | 0.549 | ||||||
|
| |||||||||||
| ALB | ALB≥40 | 22 | 11 | 14 | 19 | 20 | 13 | 4 | 29 | 9 | 24 |
| ALB<40 | 14 | 10 | 11 | 13 | 7 | 17 | 12 | 12 | 5 | 19 | |
| X2/t | 0.415 | 0.066 | 5.509 | 8.087 | 0.311 | ||||||
| P Value | 0.520 | 0.798 | 0.019 ∗ | 0.004 ∗ | 0.577 | ||||||
Using chi square test, we estimate the baseline characteristics of patients with mCRC grouped by the levels of LDH, SLA, and ALB.
∗ We define P < 0.05 as statistical difference.